Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: A multicenter, open-label, single-arm study (Diabetes Metab J 2013;37:117-24)

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: A multicenter, open-label, single-arm study (Diabetes Metab J 2013;37:117-24)'. Together they form a unique fingerprint.